STILNOX

This brand name is authorized in Brazil, Cyprus, Germany, Estonia, Spain, France, Hong Kong, Israel, Lithuania, Malta, Mexico, Poland, Romania, Singapore, Tunisia, South Africa

Active ingredients

The drug STILNOX contains one active pharmaceutical ingredient (API):

1 Zolpidem hemitartrate UNII WY6W63843K - ZOLPIDEM TARTRATE

Zolpidem is an imidazopyridine which preferentially binds the omega-1 receptor subtype (also known as the benzodiazepine-1 subtype) which corresponds to GABA-A receptors containing the alpha-1 sub-unit, whereas benzodiazepines non-selectively bind both omega-1 and omega-2 subtypes. The modulation of the chloride anion channel via this receptor leads to the specific sedative effects demonstrated by zolpidem. These effects are reversed by the benzodiazepine antagonist flumazenil. Read about Zolpidem

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
STILNOX Film-coated tablet	Web Search	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05CF02	Zolpidem	N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CF Benzodiazepine related drugs
Discover more medicines within N05CF02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 576720070081017, 576720070081117, 576720070081217, 576720070081317, 576720070081417, 576720070081517, 576721070095603, 576721070095703, 576721070095803
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00198344, 00723394, 00723595, 07243993, 07244001, 07478319, 07709724, 07711218, 15235186, 17866169, 17928479, 17938319
Country: EE	Ravimiamet	Identifier(s): 1043211, 1068106, 1822317
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 58470
Country: FR	Base de données publique des médicaments	Identifier(s): 63179285
Country: HK	Department of Health Drug Office	Identifier(s): 36433, 56391, 56392
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3374, 9349
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1009438, 1009439, 1078646, 1080561, 1081953, 1090060, 1091093
Country: MT	Medicines Authority	Identifier(s): MA1359/03401, PI242/01401A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 044M98, 152M2008
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100063983, 100216702, 100271664, 100348378, 100354812, 100365649, 100462391
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W62440001, W62440002, W62440003, W62440004
Country: SG	Health Sciences Authority	Identifier(s): 07418P, 13402P, 13403P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6463052
Country: ZA	Health Products Regulatory Authority	Identifier(s): 29/2.2/0651